Recipharm bolsters development business with new appointments in the US and Europe
Recipharm, the contract development and manufacturing organisation (CDMO), has appointed Anders Högdin and Aaron Small to lead the growth of its pharmaceutical development services business in the US and Europe.Since forming in Sweden in 1995, Recipharm has experienced strong year-on-year growth and is now operating from 20+ sites across 10 countries. In addition to its manufacturing services offering, Recipharm delivers pharmaceutical development services from the early discovery phase to supply of clinical trial materials from facilities in Sweden, Italy, France, Israel and the US.